|
Sep 27
|
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
|
|
Sep 6
|
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
|
Sep 3
|
Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock
|
|
Aug 30
|
Krystal Biotech Stock Surges 21.9% in 3 Months: More Room to Grow?
|
|
Aug 28
|
Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté
|
|
Jul 30
|
Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
|
|
Jul 26
|
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
|
|
Jun 21
|
Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin
|
|
Jun 17
|
3 US Growth Companies With High Insider Ownership And Up To 96% Earnings Growth
|
|
May 17
|
3 High Insider Ownership US Stocks With Up To 55% Revenue Growth
|
|
May 15
|
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
|
|
May 8
|
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
|
|
May 7
|
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Krystal Biotech Inc (KRYS) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and ...
|
|
May 7
|
Q1 2024 Krystal Biotech Inc Earnings Call
|
|
May 6
|
Krystal Biotech Inc (KRYS) Surpasses Revenue Estimates in Q1 2024
|
|
May 6
|
Krystal Biotech, Inc. (KRYS) Q1 Earnings and Revenues Miss Estimates
|
|
May 6
|
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 3
|
Why Krystal Biotech (KRYS) Might Surprise This Earnings Season
|
|
May 2
|
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
|